HS Icon Blood, antisera, vaccines, toxins and cultures in  Flag Japan

2019
Exports | Imports
: $1.74B | $7.06B, World Rnk 15 / 201
Flag Rnk 81 / 1200 | World Rnk 10 / 222
Flag Rnk 15 / 1211

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $224M | $457M, United States |  Ireland

2019
ECONOMIC COMPLEXITY of Japan
: 2.23, Rnk 1 / 147

2019
PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures
: 1.19, Rnk 110 / 1029

Exports: In 2019, Japan exported $1.74B in Blood, antisera, vaccines, toxins and cultures, making it the 15th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 81st most exported product in Japan. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Japan are: United States ($506M), Switzerland ($412M), Germany ($159M), United Kingdom ($122M), and China ($114M).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Japan between 2018 and 2019 were United States ($224M), United Kingdom ($79.8M), and Thailand ($16.3M).

Imports: In 2019, Japan imported $7.06B in Blood, antisera, vaccines, toxins and cultures, becoming the 10th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 15th most imported product in Japan. Japan imports Blood, antisera, vaccines, toxins and cultures primarily from: United States ($1.72B), Ireland ($1.69B), Switzerland ($1.39B), Germany ($1.14B), and Belgium ($265M).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Japan between 2018 and 2019 were Ireland ($457M), Italy ($110M), and Switzerland ($104M).

Latest Trends (May 2021)

#permalink to section

Overview: In May 2021 Japan's Blood, antisera, vaccines, toxins and cultures exports accounted up to ¥17.4B and imports accounted up to ¥230B, resulting in a negative trade balance of ¥213B. Between May 2020 and May 2021 the exports of Japan's   Blood, antisera, vaccines, toxins and cultures have decreased by ¥-8.86B (-33.8%) from ¥26.2B to ¥17.4B, while imports increased by ¥158B (217%) from ¥72.6B to ¥230B.

Destinations: In May 2021, Blood, antisera, vaccines, toxins and cultures were exported mostly to Switzerland (¥5.51B), United States (¥4.25B), South Korea (¥1.65B), United Kingdom (¥1.21B), and Germany (¥1.18B), and were imported mostly from Belgium (¥85.9B), United States (¥58.5B), Switzerland (¥19.4B), Ireland (¥18.8B), and Spain (¥14.2B).

Growth: In May 2021, the decrease in Blood, antisera, vaccines, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to United States (¥-13B or -75.3%), Nigeria (¥-398M or -100%), and France (¥-391M or -54.5%). In May 2021, the increase in Blood, antisera, vaccines, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Belgium (¥82.8B or 2.71k%), United States (¥46.5B or 385%), and Spain (¥14B or 6.31k%).

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (May 2020 - May 2021): ¥-8.86B, (-33.8%)

IMPORT GROWTH (May 2020 - May 2021): ¥158B, (217%)

MAIN EXPORTER (May 2021): Chiba, ¥9.36B

MAIN DESTINATION (May 2021): Switzerland, ¥5.51B

This section shows Blood, antisera, vaccines, toxins and cultures's exports and imports data at subnational level for Japan. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Blood, antisera, vaccines, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value

EXPORTS (2019): $1.74B

IMPORTS (2019): $7.06B

NET TRADE (2019): -$5.31B

In 2019, Japan exported $1.74B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Japan exports on Blood, antisera, vaccines, toxins and cultures were United States ($506M), Switzerland ($412M), Germany ($159M), United Kingdom ($122M), and China ($114M).

In 2019, Japan imported $7.06B in Blood, antisera, vaccines, toxins and cultures, mainly from United States ($1.72B), Ireland ($1.69B), Switzerland ($1.39B), Germany ($1.14B), and Belgium ($265M).

Explore Visualizations

IN 2019, Japan HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2019, Japan HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Japan WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Japan WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, Japan's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2018, Japan's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2018, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Japan were of 0% around the world.